Physician profile
Seyed Mohammad Reza Khalafi
NPI 1265457071
$66,051.48
in general payments reported to CMS, 2019-2025
24 companies · $6,215 in 2025
The $6,215 reported for 2025 was more than what 85% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $2,804 · 2021: $6,135 · 2022: $22K · 2023: $14K · 2024: $5,266 · 2025: $6,215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Travel and Lodging: $3,579 · Royalty Or License: $3,523 · Consulting Fee: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,026.27 |
| Travel and Lodging | $3,578.77 |
| Royalty Or License | $3,523.10 |
| Consulting Fee | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cmf Medicon Surgical INC. | $19,229.80 | 2022-2023 | |
| Getinge USA Sales, LLC | $17,502.91 | 2019-2025 | Acrobat-I Stabilizer, Vasoview Hemopro 2, Heartstring III Proximal Seal |
| Abbott Laboratories | $7,271.47 | 2019-2025 | Amplatzer, Thoratec Heartmate 3 Lvas Implant Kit |
| Edwards Lifesciences Corporation | $4,212.32 | 2019-2025 | Sapien 3 Ultra Resilia, Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve |
| Atricure, INC. | $3,576.43 | 2021-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Boston Scientific Corporation | $2,976.26 | 2019-2025 | Opticross 6, Avvigo Guidance System, Comet |
| Baxter Healthcare | $2,200.56 | 2019-2025 | Coseal, Perclot, Surgical Tools |
| Maquet Cardiovascular L.L.C. | $1,997.75 | 2022-2025 | Heartstring III Proximal Seal, Acrobat-I Stabilizer, Vasoview Hemopro 2 |
| Abiomed | $1,750.88 | 2019-2025 | Impella |
| Artivion, INC. | $1,270.24 | 2019-2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive, Amds-Ascyrus Medical |
| Stryker Corporation | $1,135.63 | 2020-2022 | |
| Pylant Medical | $624.89 | 2024-2025 | |
| Medtronic Vascular, INC. | $447.34 | 2019-2020 | |
| Shockwave Medical, INC | $354.77 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $344.83 | 2024 | Orsiro Mission, Recross |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $295.16 | 2024-2025 | Prolene, Echelon Endopath, Ethicon |
| Penumbra, INC. | $273.91 | 2019-2023 | Indigo System |
| Medtronic, INC. | $211.04 | 2021-2025 | Corevalve Evolut R |
| Depuy Synthes Sales INC. | $117.21 | 2021-2025 | Matrixrib |
| Cardiovascular Systems INC. | $71.33 | 2023 | Diamondback Peripheral |
| Bolton Medical INC | $70.57 | 2025 | Treo Abdominal Stent-Graft System |
| Biosense Webster, INC. | $66.34 | 2019 | |
| Janssen Pharmaceuticals, INC | $25.84 | 2020 | |
| Arthrex, INC. | $24.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$55.74 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seyed Mohammad Khalafi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.